Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P.
Lautamäki R, et al. Among authors: airaksinen ke.
Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E282-90. doi: 10.1152/ajpendo.00604.2005. Epub 2006 Feb 14.
Am J Physiol Endocrinol Metab. 2006.
PMID: 16478772
Free article.
Clinical Trial.